Chronic / Neuro Lyme Study in Wisconsin is open to applicants

Chronic / Neuro Lyme Study in Wisconsin is open to applicants

A case study of chronic/ neuro Lyme patients is underway and clients are being accepted. The study is located in South Central Wisconsin. The study is expected to run through July 2014. HBOT will be provided to participants at a 75% discounted rate for the duration of the study.

Please contact the study coordinator for more info and/or application materials at info@o2clinics.com or 920.699.3399.

Study Requirements:

Lyme sufferers seeking inclusion are required to::
• Be under the care of a Physician
• Complete the admission application
• Complete the initial symptom inventory
• Complete history of illness and symptoms
• Keep a log / diary of treatments, herxing and daily neurologic and health summaries
• Agree to allow this information to be organized and published - Names will not be published

The Study will 
• Provide two HBOT treatments per day at 2.4ATA at cost of $55 ea for the duration, up to 160 treatments
• Provide lodging at $25 - $45 per night 
• If patients withdraw from the study after the 10th treatment and before the 11th treatment, cost is limited to $100

Study outline - Borrelia Borgdoferi is a facultative anaerobic organism which has been shown to be incapable of surviving in partial pressures of oxygen above 160 mmHg1. Hyperbaric Oxygen treatments can raise the partial pressure of oxygen in body tissues including the brain and central nervous system above 300 mmHg. When Lyme becomes chronic and the spirochete is sequestered in cells, the cells may protect the spirochete against the antibiotic making it less effective. This may be further complicated by the Blood Brain Barrier which further protects the neurons from pathogens and antibiotics. It is hypothesized in this study that Hyperbaric Oxygen treatments, by increasing the permeability of the Blood Brain Barrier2 (BBB) will work as an adjunct and an adjuvant to allopathic and natural antibiotics to increase the antibiotic concentration in the Neuron. We theorize that the increased oxygen in the neuron will produce an oxygen environment which is lethal to the Bb Spirochete. It is further theorized that the HBOT will optimize the metabolism of the Neuron and promote efficient transport of the toxic load from the expired Bb Spirochetes away from the Neurons to be eliminated from the body thus reducing the Herxheimer reaction. Finally, Hyperbaric Oxygen Therapy has been shown to increase the number of stem cells in the body by 8 fold after 20 hours of therapy3. It is theorized that these stem cells will differentiate into neurons providing improved cognition and physical capabilities.

1 Austin, F., Maintenance of infective Borrelia burgdorferi Sh-2-82 in 4% oxygen - 5% carbon dioxide in vitro. Canadian J. Microbiol. 39(12):1103-10, 1993 Dec.http://www.ncbi.nlm.nih.gov/pubmed/8131108

2 Lance et al 1978 - Changes in the permeability of the blood-brain barrier under hyperbaric conditions. http://www.ncbi.nlm.nih.gov/pubmed/666682

3 Thom et al 2006 - Stem cell mobilization by hyperbaric oxygenhttp://ajpheart.physiology.org/content/ajpheart/290/4/H1378.full.pdf

For more information
920.699.3399
info@o2clinics.com
Study location - http://www.o2clinics.com/contact-us.html